NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

MD | NYSE

$26.61 -$0.31 | -1.15%
TREND SIGNAL:Signal available — unlock to view |2026-10-13

Company Overview:

Market Cap: $2.11B
Trailing PE: 12.7x
FWD PE *: 11.2x
Payout Ratio (TTM): —
52-Week Range: $15.82 - $27.94

* Forward PE is based on street estimates.

10 Year MD Performance Metrics:

Total Return (with DRIP): -59.8% (-8.71% CAGR)
Total Return (no DRIP): -59.8% (-8.71% CAGR)
Share Price: -59.8% (-8.71% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $4,022
Total Return $ (with DRIP): -$5,978
MD Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
MD Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

MD Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

MD - Revenue
MD Revenue CAGR:1Y: 4.04%2Y: -1.65%5Y: 0.62%10Y: -4.48%
MD - Earnings Per Share (EPS)
MD EPS CAGR:1Y: 8.89%2Y: 0.00%5Y: 3.63%10Y: -5.79%
MD - Net Income
🔓 See the full chart40% off right now · 7-day free trial
MD Net Income CAGR:1Y: 1.48%2Y: 0.00%5Y: 2.62%10Y: -7.01%
MD - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
MD EBITDA CAGR:1Y: 3.56%2Y: 0.00%5Y: 3.22%10Y: -8.18%
MD - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
MD Free Cash Flow CAGR:1Y: -6.56%2Y: 11.34%5Y: 22.96%10Y: -1.28%
MD - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
MD Free Cash Flow / Share CAGR:1Y: 2.16%2Y: 14.03%5Y: 24.61%10Y: 0.20%
MD - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
MD Operating Income CAGR:1Y: 9.24%2Y: 15.81%5Y: 5.51%10Y: -7.83%
MD - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
MD Gross Profit CAGR:1Y: 6.21%2Y: 12.15%5Y: 0.11%10Y: -6.53%
MD - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
MD Shares Outstanding CAGR:1Y: -6.27%2Y: -1.16%5Y: -1.08%10Y: -1.32%
MD - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
MD Share Buybacks CAGR:1Y: 20,351.67%2Y: 6,133.63%5Y: 179.41%10Y: 29.66%
MD - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
MD Stock-Based Comp CAGR:1Y: 29.83%2Y: 61.24%5Y: -2.42%10Y: -4.83%
MD - Expenses
🔓 See the full chart40% off right now · 7-day free trial
MD Expenses CAGR:1Y: -69.46%2Y: -55.49%5Y: -32.00%10Y: -16.85%
MD - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
MD - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
MD - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
MD - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
MD - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
MD - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
MD - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
MD Revenue CAGR:1Y: 4.04%2Y: -1.65%5Y: 0.62%10Y: -4.48%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

MD - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
MD Actual Revenue CAGR:1Y: 4.04%2Y: -1.65%5Y: 0.62%10Y: -4.48%
MD - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
MD Actual EPS CAGR:1Y: 8.89%2Y: 0.00%5Y: 3.63%10Y: -5.79%
MD - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
MD Actual Net Income CAGR:1Y: 1.48%2Y: 0.00%5Y: 2.62%10Y: -7.01%
MD - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
MD Actual EBITDA CAGR:1Y: 3.56%2Y: 0.00%5Y: 3.22%10Y: -8.18%

Ratios, Profit Margins & Return on Capital:

MD - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
MD Net Profit Margin CAGR:1Y: -2.39%2Y: 0.00%5Y: 2.00%10Y: -2.64%
MD - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
MD Gross Profit Margin CAGR:1Y: 2.11%2Y: 14.02%5Y: -0.50%10Y: -2.14%
MD - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
MD Price to Earnings CAGR:1Y: 58.86%2Y: 0.00%5Y: -7.08%10Y: -4.58%
MD - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
MD Price To Sales Ratio CAGR:1Y: 55.18%2Y: 87.38%5Y: -5.29%10Y: -7.14%
MD - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
MD Return on Capital Employed CAGR:1Y: 2.80%2Y: 9.90%5Y: 9.02%10Y: 0.49%
MD - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
MD Return on Invested Capital CAGR:1Y: -3.41%2Y: -5.17%5Y: 1.26%10Y: 0.11%

Compare stocks side-by-side

Projected Future Returns & Dividends for MD

Based on past 10-year performance, here are MD growth metrics:

Share price CAGR of -8.71%
Dividend CAGR of +0%

Using MD CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

MD (DRIP)MD - No DRIP
Current Price$26.61$26.61
Start Shares375.80375.80
Start Value$10,000$10,000
  
After 10 years:
Final Share Count375.80375.80
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$10.70$26.61
Total Dividends$0$0
Final Value$4,022$10,000

Estimated Future Value + Dividends - MD

NOTE: Above numbers are our estimate based on MD's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

Pediatrix Medical Group, Inc. (MD) had its IPO on 1995-09-20, and is traded on NYSE stock exchange.

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.

MD website: https://www.pediatrix.com


Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — MD

Value from:
Pay up to today
—
vs current price $26.61
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →